Mouse Anti HIV-I Rev (Clone 6)

The HIV-1 Rev protein mediates the nuclear export of viral mRNA, and is thereby essential for the production of late viral proteins in the replication cycle. Rev forms a large organized multimeric protein-protein complex for proper functioning. Monoclonal anti HIV-1 REV antibody Clone 6 is designed for the detection of REV in human serum or plasma from infected individuals as well as in cell culture supernatant.

SKU: ANT0060 Categories: , , ,
Product type: Reagents for research
Reagent type: Antibody
Size: 50 µg

Description

Three major regions of the Rev protein are required for it to help HIV replication: an RNA binding region, an oligomerization region, and a Nuclear Export Signal. The RNA binding region interacts with a part of the viral RNA called the Rev-Responsive Element (RRE). A small (∼30 nucleotides) binding site within this element has a high affinity for Rev, forming a larger complex. The RNA binding region of Rev forms an alpha helix that docks into a complementary groove in the high affinity binding site on RRE . Adding more Rev proteins onto the RRE results in the formation of a series of larger complexes, but where these additional Rev molecules bind is not known yet. The one exception is a weak secondary Rev binding site that has been identified adjacent to the high affinity site.

Additional information

Size 50 µg
Application Clinical diagnostics| Life Sciences
Product type Reagents for research
Reagent type Antibody
Category HIV
Subcategory Mouse monoclonal IgG1 with a k light chain
Antibody type Primary antibody
Immunogen HIV-1 Rev recombinant protein His-6 Tag (Clade B, HXB-3 isolate)

Technical information

Size 50 µg
Purity Purified from supernatants of hybridoma cell cultures by affinity chromatography
Form Liquid. Supplied in 100mM sodium citrate, 50mM Tris and 0.05% v/v glycerol. Neutral pH.
Shipping/storage conditions Shipped at 2-8°C. When stored at +4°C the antibody is stable for 18 months. For extended storage up to 24 months, the solution may be frozen at -20°C in working aliquots. Avoid repested freezing and thawing cycles.
Usage For Laboratory Research Use Only
Source Mouse
Specificity REV protein from HIV-1 virus in human specimens
React with REV HIV-1 viral protein
Recommended dilutions Recommended starting dilutions can vary lot-to-lot. Consult the suggested starting dilutions on the top of the page for lot specific values.

Download

References

Related products

Recombinant TAT Clade B BIOTIN
HIV-1 TAT Recombinant Tat Clade B Biotein conjugated, is produced in E.coli and conjugated with NHS Biotin.
REP0004
Recombinant TAT Clade B
HIV-1 TAT Recombinant- produced in E.coli is a single, non-glycosylated, polypeptidic chain containing 86 amino acids encoded by two exons and having a molecular mass of 14kDa.
REP0002a
Recombinant TAT Clade B
HIV-1 TAT Recombinant- produced in E.coli is a single, non-glycosylated, polypeptidic chain containing 86 amino acids encoded by two exons and having a molecular mass of 14kDa.
REP0002b
Recombinant TAT Cys22
HIV-1 regulatory Tat protein plays an essential role in viral replication and infectivity. In addition, during acute infection, Tat is released extracellularly by infected cells and is taken up by neighbouring cells where it transactivates viral replication and increases virus infectivity. The Tat cys22 protein of HIV-1 is a molecule of 86 aminoacids mutated in the trans activation domain.
REP0033
Recombinant TAT Clade C
Recombinant (HIV-1) Tat Clade C produced in E.coli. The HIV-1 Tat protein Clade C is a molecule of 101 aminoacids encoded by two exons.
REP0030
Recombinant TAT Clade D
Recombinant (HIV-1) Tat clade D produced in E. coli. Productive HIV-1 replication is absolutely dependent upon the viral tat protein. In Uganda Clades A and D are responsible for approximately 95% of HIV-1 infections. The HIV-1 tat protein Clade A is a molecule of 86 aminoacids encoded by two exons and having a molecular mass of 18 kDa in SDS-PAGE.
REP0044
Recombinant TAT Clade D
Recombinant (HIV-1) Tat clade D produced in E. coli. Productive HIV-1 replication is absolutely dependent upon the viral tat protein. In Uganda Clades A and D are responsible for approximately 95% of HIV-1 infections. The HIV-1 tat protein Clade A is a molecule of 86 aminoacids encoded by two exons and having a molecular mass of 18 kDa in SDS-PAGE.
REP0045
Recombinant TAT Clade B C27A-C31A Mutant
Recombinant HIV-1 TAT Clade B C31A-C34A is produced in E.coli and is mutate in the cystein-rich region. It Is a single, non-glycosylated, polypeptidic chain containing 86 amino acids encoded by two exons.
REP0061
Recombinant TAT Clade B C31A-C34A Mutant
Recombinant HIV-1 TAT Clade B C31A-C34A is produced in E.coli and is mutate in the cystein-rich region. It Is a single, non-glycosylated, polypeptidic chain containing 86 amino acids encoded by two exons.
REP0062
Recombinant TAT CRF02_AG
Recombinant (HIV-1) CRF02_AG Tat produced in E.coli. The HIV-1 CFR02_AG Tat protein is a molecule of 101 aminoacids encoded by two exons and having a molecular mass of 20.1kDa in SDS-PAGE.
REP0059
Recombinant TAT CRF02_AG
Recombinant (HIV-1) CRF02_AG Tat produced in E.coli. The HIV-1 CFR02_AG Tat protein is a molecule of 101 aminoacids encoded by two exons and having a molecular mass of 20.1kDa in SDS-PAGE.
REP0060
Rabbit Anti HIV-1 Tat Biotin conjugated
The rabbit polyclonal Anti HIV-1 Tat antibody Biotin conjugated is a useful tool for detecting Tat transactivating regulatory protein. The conjugation garantees an improvement on the specific signal and the best signal on semidirect immunological methods
ANT0003
Rabbit Anti HIV-I Tat FITC conjugated
The rabbit polyclonal Anti HIV-1 Tat antibody FITC conjugated is a useful tool for detecting Tat transactivating regulatory protein. The florophore conjugation garantees an improvement on the specific signal and the best signal on fluorescence methodologies
ANT0005
Rabbit Anti HIV-I Tat affinity purified
The rabbit polyclonal Anti HIV-1 Tat antibody affinity purified is a useful tool for detecting Tat transactivating regulatory protein. The affinity purification protocol garantees an improvement on the specific signal
ANT0041
Recombinant TAT Clade A
Recombinant (HIV-1) Tat clade A produced in E. coli. Productive HIV-1 replication is absolutely dependent upon the viral tat protein. In Uganda Clades A and D are responsible for approximately 95% of HIV-1 infections. The HIV-1 tat protein Clade A is a molecule of 86 aminoacids encoded by two exons and having a molecular mass of 20.1 kDa in SDS-PAGE
REP0043

Information request

    Go to Top